AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Clin Nutr 90: 1230-1235, 2009. First published September 23, 2009; doi:10.3945/ajcn.2009.28151
American Journal of Clinical Nutrition, doi:10.3945/ajcn.2009.28151
Vol. 90, No. 5, 1230-1235, November 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/5/1230    most recent
ajcn.2009.28151v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Shea, M K.
Right arrow Articles by Booth, S. L
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shea, M K.
Right arrow Articles by Booth, S. L
Agricola
Right arrow Articles by Shea, M K.
Right arrow Articles by Booth, S. L
© 2009 American Society for Clinical Nutrition

ORIGINAL RESEARCH COMMUNICATION

{gamma}-Carboxylation of osteocalcin and insulin resistance in older men and women1,2,3,4

M Kyla Shea, Caren M Gundberg, James B Meigs, Gerard E Dallal, Edward Saltzman, Makiko Yoshida, Paul F Jacques and Sarah L Booth

1 From the USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA (MKS, ES, GED, PFJ, MY, and SLB); the Department of Orthopaedics, Yale University School of Medicine, New Haven, CT (CMG); and the General Medicine Division and Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA (JBM).

2 Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the US Department of Agriculture.

3 Supported by the USDA Agricultural Research Service under cooperative agreement no. 58-1950-7-707, the National Institutes of Health (grant nos. AG14759, HL69272, AR38460, and T32 HL69772-01A1), and the American Heart Association (grant no. 0515605T). JBM was supported by National Institute of Diabetes and Digestive and Kidney Diseases (grant no. K24 DK080140).

4 Address correspondence to SL Booth, USDA Human Nutrition Research Center on Aging, Tufts University, 711 Washington Street, Boston, MA 02111. E-mail: sarah.booth{at}tufts.edu.

Background: The skeletal protein osteocalcin is {gamma}-carboxylated by vitamin K. High serum uncarboxylated osteocalcin reflects low vitamin K status. In vitro and animal studies indicate that high uncarboxylated osteocalcin is associated with reduced insulin resistance. However, associations between osteocalcin and measures of insulin resistance in humans are less clear.

Objective: Our aim was to examine cross-sectional and longitudinal associations between circulating forms of osteocalcin (total, uncarboxylated, and carboxylated) and insulin resistance in older men and women.

Design: Cross-sectional associations between serum measures of total osteocalcin, carboxylated osteocalcin, and uncarboxylated osteocalcin and insulin resistance were examined in 348 nondiabetic men and women (mean age: 68 y; 58% female) by using the homeostasis model assessment of insulin resistance (HOMA-IR). Associations between each form of osteocalcin at baseline and 3-y change in HOMA-IR were examined in 162 adults (mean age: 69 y; 63% female) who did not receive vitamin K supplementation.

Results: Lower circulating uncarboxylated osteocalcin was not associated with higher HOMA-IR at baseline or at 3-y follow-up. Those in the lowest tertiles of total osteocalcin and carboxylated osteocalcin at baseline had higher baseline HOMA-IR (P = 0.006 and P = 0.02, respectively). The concentration of carboxylated osteocalcin at baseline was inversely associated with a 3-y change in HOMA-IR (P = 0.002).

Conclusions: In older adults, circulating uncarboxylated osteocalcin was not associated with insulin resistance. In contrast, elevated carboxylated osteocalcin and total osteocalcin were associated with lower insulin resistance, which supports a potential link between skeletal physiology and insulin resistance in humans. The role of vitamin K status in this association remains unclear and merits further investigation. This trial is registered at clinicaltrials.gov as NCT00183001.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The American Society for Nutrition